2026 Interim report
Filed with HKEX · Stock code 3378 · · 57 pages · English
Hanx Biopharmaceuticals (Wuhan) Co. Ltd. on 6ix
Earlier from Hanx Biopharmaceuticals (Wuhan)
- Proposed placing of unlisted warrants under Specific mandate
- Next Day Disclosure Return
- Voluntary announcement notice on voluntary extension of lock-up period by shareholders
- Voluntary announcement inclusion of Hanx Biopharmaceuticals in the FTSE global micro cap index
Later from Hanx Biopharmaceuticals (Wuhan)
- Voluntary announcement entering into strategic cooperation with xtalpi
- Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2026
Follow Hanx Biopharmaceuticals (Wuhan) into a list and get an email when it puts out news.
Follow Hanx Biopharmaceuticals (Wuhan)